Fundraising Fox

Florian Muellershausen

Investor

Managing Director at Novartis Venture Fund

Basel, Switzerland

About

Florian Muellershausen, PhD, is a Managing Director at the Novartis Venture Fund based in Basel, Switzerland. Before joining the fund, he served as a Scientific Manager for the R&D Committee of the Novartis Board of Directors and held drug discovery roles in Novartis R&D, including Laboratory Head in target discovery and Translational Medicine Expert in autoimmunity. He holds an MSc in Biochemistry from Free University Berlin, a PhD in Biochemistry from Ruhr University Bochum, and completed postdoctoral training at Novartis in Switzerland.

Invests in

Biotech

Experience

  1. Novartis Venture FundManaging Directorcurrent2019 — presentBasel Metropolitan Area
  2. Novartis Venture FundPrincipal2017 — 2019Basel, Basel, Switzerland
  3. NovartisScientific Manager, Board Office2015 — 2017Basel, Basel, Switzerland
  4. NovartisTranslational Medicine Expert - Senior Investigator II - Autoimmunity2014 — 2015Basel, Basel, Switzerland
  5. NovartisTranslational Medicine Expert - Senior Investigator I, Autoimmunity2011 — 2014Basel, Basel, Switzerland
  6. NovartisProject Team Head - Investigator III, Translational Medicine Associate Autoimmunity2010 — 2011
  7. NovartisLaboratory Head - Investigator II2007 — 2010
  8. NovartisPostdoc2005 — 2007
  9. Ruhr-Universität Bochum, Institute for PharmacologyPostdoc2003 — 2004

Education

  1. Ruhr University BochumDr. rer. nat. (PhD), Molecular Pharmacology2000 — 2003
  2. Freie Universität BerlinDiploma (eq. to MSc, Biochemistry1994 — 2000

Skills & more

Clinical Development23Translational Medicine27Signal Transduction13Molecular PharmacologyDrug Discovery32Pharmacology6Clinical Trials15PharmaceuticalsCell Biology10Genomics4Biomarker Discovery7Target Identification4
+6 moreBiomarkersClinical ResearchLife SciencesDrug discoveryDrug DevelopmentPharmaceutical Industry

From Florian's professional profile.

Same school

Shared employers

Investments

Board seats

AnaveonCitryllLoQus23 TherapeuticsONL TherapeuticsRhyGazeSalvinaSpliceBio

Per the firm's website.

Colleagues at Novartis Venture Fund

Network5

Investors connected to Florian in public investor directories — a warm-intro map.